Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Dec;65(12):5052–5056. doi: 10.1128/iai.65.12.5052-5056.1997

Protection against Pneumocystis carinii pneumonia by antibodies generated from either T helper 1 or T helper 2 responses.

B A Garvy 1, J A Wiley 1, F Gigliotti 1, A G Harmsen 1
PMCID: PMC175728  PMID: 9393795

Abstract

To determine whether different antibody isotypes associated with T helper 1 (Th1) or Th2 responses are protective against Pneumocystis carinii, mice with disrupted interleukin 4 genes (IL-4(-/-) mice) or gamma interferon genes (IFN-gamma(-/-) mice) along with wild-type C57BL/6 mice were immunized intratracheally against P. carinii, depleted of T cells in vivo by use of monoclonal antibodies, and rechallenged intratracheally with 10(7) viable P. carinii organisms. Nearly all immunized mice resolved their lung P. carinii infections (limit of detection, log10 4.06) within 21 days of challenge even though they were depleted of T cells. Unimmunized mice depleted of T cells had significant lung infections (>log10 5.5) at day 21 post-P. carinii challenge. IFN-gamma(-/-) and wild-type mice developed P. carinii-specific immunoglobulin primarily of the immunoglobulin G1 (IgG1) subclass with relatively little P. carinii-specific IgG2a, IgG2b, or IgG3 in their sera, characteristic of a Th2-type response. In contrast, IL-4(-/-) mice had primarily an IgG2b P. carinii-specific antibody response in their sera with very little IgG1. Although IgG2b was the predominant isotype in IL-4(-/-) mice, optical density values of IgG2a and IgG3 were significantly higher in these mice (two and three times, respectively) than in IFN-gamma(-/-) mice, characteristic of a Th1-type response. Together, these data indicate that resolution of P. carinii infection can be mediated by specific antibody responses and that the antibody response can be either a predominantly Th1 or Th2 type. Furthermore, although wild-type mice mounted a Th2-like antibody response, IL-4(-/-) mice could resolve P. carinii pneumonia, indicating that resistance to P. carinii can occur in the absence of IL-4.

Full Text

The Full Text of this article is available as a PDF (163.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldridge J. R., Buchmeier M. J. Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection. J Virol. 1992 Jul;66(7):4252–4257. doi: 10.1128/jvi.66.7.4252-4257.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Briles D. E., Forman C., Hudak S., Claflin J. L. The effects of subclass on the ability of anti-phosphocholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae. J Mol Cell Immunol. 1984;1(5):305–309. [PubMed] [Google Scholar]
  3. Chen W., Havell E. A., Harmsen A. G. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect Immun. 1992 Apr;60(4):1279–1284. doi: 10.1128/iai.60.4.1279-1284.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chen W., Mills J. W., Harmsen A. G. Development and resolution of Pneumocystis carinii pneumonia in severe combined immunodeficient mice: a morphological study of host inflammatory responses. Int J Exp Pathol. 1992 Dec;73(6):709–720. [PMC free article] [PubMed] [Google Scholar]
  5. Cushion M. T., Ruffolo J. J., Walzer P. D. Analysis of the developmental stages of Pneumocystis carinii, in vitro. Lab Invest. 1988 Mar;58(3):324–331. [PubMed] [Google Scholar]
  6. Garvy B. A., Ezekowitz R. A., Harmsen A. G. Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection. Infect Immun. 1997 Feb;65(2):373–379. doi: 10.1128/iai.65.2.373-379.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Garvy B. A., Harmsen A. G. Susceptibility to Pneumocystis carinii infection: host responses of neonatal mice from immune or naive mothers and of immune or naive adults. Infect Immun. 1996 Oct;64(10):3987–3992. doi: 10.1128/iai.64.10.3987-3992.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gigliotti F., Garvy B. A., Harmsen A. G. Antibody-mediated shift in the profile of glycoprotein A phenotypes observed in a mouse model of Pneumocystis carinii pneumonia. Infect Immun. 1996 Jun;64(6):1892–1899. doi: 10.1128/iai.64.6.1892-1899.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Harmsen A. G., Chen W., Gigliotti F. Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice. Infect Immun. 1995 Jul;63(7):2391–2395. doi: 10.1128/iai.63.7.2391-2395.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Harmsen A. G. Role of alveolar macrophages in lipopolysaccharide-induced neutrophil accumulation. Infect Immun. 1988 Aug;56(8):1858–1863. doi: 10.1128/iai.56.8.1858-1863.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Harmsen A. G., Stankiewicz M. Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med. 1990 Sep 1;172(3):937–945. doi: 10.1084/jem.172.3.937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R., Vilcek J., Zinkernagel R. M., Aguet M. Immune response in mice that lack the interferon-gamma receptor. Science. 1993 Mar 19;259(5102):1742–1745. doi: 10.1126/science.8456301. [DOI] [PubMed] [Google Scholar]
  13. Marcotte H., Levesque D., Delanay K., Bourgeault A., de la Durantaye R., Brochu S., Lavoie M. C. Pneumocystis carinii infection in transgenic B cell-deficient mice. J Infect Dis. 1996 Apr;173(4):1034–1037. doi: 10.1093/infdis/173.4.1034. [DOI] [PubMed] [Google Scholar]
  14. Mosmann T. R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today. 1996 Mar;17(3):138–146. doi: 10.1016/0167-5699(96)80606-2. [DOI] [PubMed] [Google Scholar]
  15. Mukherjee S., Lee S. C., Casadevall A. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect Immun. 1995 Feb;63(2):573–579. doi: 10.1128/iai.63.2.573-579.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Noben-Trauth N., Kropf P., Müller I. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science. 1996 Feb 16;271(5251):987–990. doi: 10.1126/science.271.5251.987. [DOI] [PubMed] [Google Scholar]
  17. Peglow S. L., Smulian A. G., Linke M. J., Pogue C. L., Nurre S., Crisler J., Phair J., Gold J. W., Armstrong D., Walzer P. D. Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis. 1990 Feb;161(2):296–306. doi: 10.1093/infdis/161.2.296. [DOI] [PubMed] [Google Scholar]
  18. Roths J. B., Sidman C. L. Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice. J Clin Invest. 1992 Aug;90(2):673–678. doi: 10.1172/JCI115910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sanford J. E., Lupan D. M., Schlageter A. M., Kozel T. R. Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide. Infect Immun. 1990 Jun;58(6):1919–1923. doi: 10.1128/iai.58.6.1919-1923.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Shellito J., Suzara V. V., Blumenfeld W., Beck J. M., Steger H. J., Ermak T. H. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest. 1990 May;85(5):1686–1693. doi: 10.1172/JCI114621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Snapper C. M., McIntyre T. M., Mandler R., Pecanha L. M., Finkelman F. D., Lees A., Mond J. J. Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med. 1992 May 1;175(5):1367–1371. doi: 10.1084/jem.175.5.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Snapper C. M., Paul W. E. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science. 1987 May 22;236(4804):944–947. doi: 10.1126/science.3107127. [DOI] [PubMed] [Google Scholar]
  23. Utsuyama M., Albright J. W., Holmes K. L., Hirokawa K., Albright J. F. Changes in the subsets of CD4+ T cells in Trypanosoma musculi infection: delay of immunological cure in young mice and the weak ability of aged mice to control the infection. Int Immunol. 1994 Aug;6(8):1107–1115. doi: 10.1093/intimm/6.8.1107. [DOI] [PubMed] [Google Scholar]
  24. Vajdy M., Kosco-Vilbois M. H., Kopf M., Köhler G., Lycke N. Impaired mucosal immune responses in interleukin 4-targeted mice. J Exp Med. 1995 Jan 1;181(1):41–53. doi: 10.1084/jem.181.1.41. [DOI] [PubMed] [Google Scholar]
  25. Vitetta E. S., Ohara J., Myers C. D., Layton J. E., Krammer P. H., Paul W. E. Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1. J Exp Med. 1985 Nov 1;162(5):1726–1731. doi: 10.1084/jem.162.5.1726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wechsler D. S., Kongshavn P. A. Further characterization of the curative antibodies in Trypanosoma musculi infection. Infect Immun. 1988 Sep;56(9):2379–2384. doi: 10.1128/iai.56.9.2379-2384.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wiley J. A., Harmsen A. G. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J Immunol. 1995 Oct 1;155(7):3525–3529. [PubMed] [Google Scholar]
  28. Yap G. S., Stevenson M. M. Differential requirements for an intact spleen in induction and expression of B-cell-dependent immunity to Plasmodium chabaudi AS. Infect Immun. 1994 Oct;62(10):4219–4225. doi: 10.1128/iai.62.10.4219-4225.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES